- This event has passed.
UMDF Bench-to-Bedside Clinical Trials Update – Part 2
January 5 @ 12:00 pm - 1:00 pm
UMDF Bench-to-Bedside – Clinical Trials Update – Part 2
Moderator: Philip Yeske, PhD and Amel Karaa, MD
Mitochondrial Disease Clinical Trial Updates – Part 2
Speakers:
- Patrice Rioux, PhD, Co-Founder, Director and CEO, Thiogenesis Therapeutics
- Robert Fischer, PhD, CEO/CSO, OMEICOS Therapeutics
- Niven R. Narain, PhD, President & CEO, BPGBio
- Ashish Dugar, PhD, MBA, Chief Development Officer, Pretzel Therapeutics
- Sharon Hamm, PharmD, Senior Vice President, Saol Therapeutics
- Giovanni Passiatore, Senior Director, Medical Affairs, Chiesi Global Rare Diseases
- Daniel DiPietro, Co-Founder, Pierrepont Therapeutics
Time: 12:00pm ET/11:00am CT/9:00a PT

